Document is current

Article History

Received: 23 September 2025

Accepted: 9 December 2025

First Online: 31 January 2026

Declarations

:

: All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Study design and data collection were approved by institutional ethics committees.

: Due to the retrospective collection of anonymized data following institutional policy, formal written consent is not required for this type of study.

: CK serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). TL serves or previously served as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), CERUS Endovascular (Fremont, CA, USA), Phenox (Bochum, Germany), Stryker (Kalamazoo, MI, USA), and Medtronic (Dublin, Ireland). DZ is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany). FD serves as consultant/proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), Balt (Irvine, CA, USA), Cerenovus/Johnson&Johnson (Irvine, CA, USA); received speakers honoraria from Cerenovus/Johnson&Johnson (Irvine, CA, USA), Acandis (Pforzheim, Germany), Asahi (Tokyo, Japan), Q`Apel (Fremont, CA, USA), Penumbra (Alameda, CA, USA), Medtronic (Dublin, Ireland), Stryker (Kalamazoo, MI, USA); received scientific grants from Cerenovus/Johnson&Johnson (Irvine, CA, USA).SH received travel support by Medtronic (Dublin, Ireland).